Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitrios Karantanis

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
European Journal of Radiology|September 1, 2009
18F-FDG PET and PET/CT in Burkitt's lymphomaDimitrios Karantanis, Jolanta M Durski, Val J Lowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physiciansDimitrios Karantanis, Dimitrios Kalkanis, Johannes Czernin, et al.
Clinical Lymphoma & Myeloma|May 27, 2008
The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphomaDimitrios Karantanis, Rathan M Subramaniam, Patrick J Peller, et al.
Nuclear Medicine Communications|September 29, 2007
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patientsDimitrios Karantanis, Brian P O'eill, Rathan M Subramaniam, et al.
Thyroid : Official Journal of the American Thyroid Association|July 18, 2008
18F-FDG PET in the management of patients with anaplastic thyroid carcinomaTrond Velde Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2007
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid glandDimitrios Karantanis, Trond V Bogsrud, Gregory A Wiseman, et al.
Molecular Imaging and Biology|December 2, 2009
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinomaTrond Velde Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
Nuclear Medicine Communications|February 1, 2011
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodiesTrond Velde Bogsrud, Ian D Hay, Dimitrios Karantanis, et al.
Nuclear Medicine Communications|April 7, 2007
The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CTTrond V Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
Hemasphere|November 29, 2023
PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?Theodoros P Vassilakopoulos, Alexia Piperidou, Zois Mellios, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Radiology|September 1, 2009
18F-FDG PET and PET/CT in Burkitt's lymphomaDimitrios Karantanis, Jolanta M Durski, Val J Lowe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2014
Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physiciansDimitrios Karantanis, Dimitrios Kalkanis, Johannes Czernin, et al.
Clinical Lymphoma & Myeloma|May 27, 2008
The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphomaDimitrios Karantanis, Rathan M Subramaniam, Patrick J Peller, et al.
Nuclear Medicine Communications|September 29, 2007
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patientsDimitrios Karantanis, Brian P O'eill, Rathan M Subramaniam, et al.
Thyroid : Official Journal of the American Thyroid Association|July 18, 2008
18F-FDG PET in the management of patients with anaplastic thyroid carcinomaTrond Velde Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2007
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid glandDimitrios Karantanis, Trond V Bogsrud, Gregory A Wiseman, et al.
Molecular Imaging and Biology|December 2, 2009
The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinomaTrond Velde Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
Nuclear Medicine Communications|February 1, 2011
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography in patients with differentiated thyroid carcinoma and circulating antithyroglobulin autoantibodiesTrond Velde Bogsrud, Ian D Hay, Dimitrios Karantanis, et al.
Nuclear Medicine Communications|April 7, 2007
The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CTTrond V Bogsrud, Dimitrios Karantanis, Mark A Nathan, et al.
Hemasphere|November 29, 2023
PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?Theodoros P Vassilakopoulos, Alexia Piperidou, Zois Mellios, et al.
Pageof 2